Molecular mechanisms of vascular permeability in diabetic retinopathy.
暂无分享,去创建一个
T. Gardner | A. Barber | D. Antonetti | E. Lieth | T. Gardner | E Lieth | D A Antonetti | A J Barber | T W Gardner
[1] J. Cunha-Vaz,et al. Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier. , 1966, The British journal of ophthalmology.
[2] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[3] D. Paul,et al. COOH Terminus of Occludin Is Required for Tight Junction Barrier Function in Early Xenopus Embryos , 1997, The Journal of cell biology.
[4] A. Barber,et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. , 1998, Diabetes.
[5] J. Tarbell,et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.
[6] C. Michel,et al. Openings Through Endothelial Cells Associated with Increased Microvascular Permeability , 1999, Microcirculation.
[7] Thomas S. Reese,et al. FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE , 1967, The Journal of cell biology.
[8] K. Nakagawa,et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[9] P Massin,et al. Growth factors and diabetic retinopathy. , 1997, Diabetes & metabolism.
[10] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[11] D. McDonald,et al. Endothelial Gaps as Sites for Plasma Leakage in Inflammation , 1999, Microcirculation.
[12] V. J. Venema,et al. VEGF-induced permeability increase is mediated by caveolae. , 1999, Investigative ophthalmology & visual science.
[13] J. Tarbell,et al. Physiological transport properties of cultured retinal microvascular endothelial cell monolayers. , 1997, Current eye research.
[14] R. Klein,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. , 1995, Ophthalmology.
[15] G. Palade,et al. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.
[16] Douglas Hanahan,et al. Signaling Vascular Morphogenesis and Maintenance , 1997, Science.
[17] L. Gu,et al. ZO-3, a Novel Member of the MAGUK Protein Family Found at the Tight Junction, Interacts with ZO-1 and Occludin , 1998, The Journal of cell biology.
[18] L. Rubin,et al. A cell culture model of the blood-brain barrier , 1991, The Journal of cell biology.
[19] S. Citi,et al. Tight junction proteins. , 1998, Biochimica et biophysica acta.
[20] Hidehiro Ishii,et al. Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.
[21] P. Campochiaro,et al. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. , 1995, Experimental eye research.
[22] T. Gardner,et al. Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1 , 1999, The Journal of Biological Chemistry.
[23] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[24] C. V. Van Itallie,et al. Tight junctions and the molecular basis for regulation of paracellular permeability. , 1995, The American journal of physiology.
[25] K. Fujimoto,et al. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Dvorak,et al. Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea‐fig, mouse and rat: many are transcellular pores , 1997, The Journal of physiology.
[27] H. Dvorak,et al. Pathways of Macromolecular Extravasation Across Microvascular Endothelium in Response to VPF/VEGF and Other Vasoactive Mediators , 1999, Microcirculation.
[28] J. Isner,et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.
[29] C. Zucker,et al. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. , 1998, The American journal of pathology.
[30] M. Itoh,et al. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues , 1996, The Journal of cell biology.
[31] James M. Anderson,et al. Molecular architecture of tight junctions. , 1998, Annual review of physiology.
[32] Daniel B. Rifkin,et al. Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.
[33] G. Lutty,et al. Localization of vascular endothelial growth factor in human retina and choroid. , 1996, Archives of ophthalmology.
[34] M. Itoh,et al. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions , 1994, The Journal of cell biology.
[35] B. Keon,et al. The tight junction: morphology to molecules. , 1998, Annual review of cell and developmental biology.
[36] C. V. Van Itallie,et al. Occludin confers adhesiveness when expressed in fibroblasts. , 1997, Journal of cell science.
[37] C. Kevil,et al. Expression of Zonula Occludens and Adherens Junctional Proteins in Human Venous and Arterial Endothelian Cells: Role of Occludin in Endothelial Solute Barriers , 1998, Microcirculation.
[38] R. D. Lynch,et al. Occludin is a functional component of the tight junction. , 1996, Journal of cell science.
[39] H. Hammes,et al. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. , 1998, Diabetes.
[40] S. Nigam,et al. Molecular structure and assembly of the tight junction. , 1998, American journal of physiology. Renal physiology.
[41] G. Palade,et al. JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA , 1963, The Journal of cell biology.
[42] M. Itoh,et al. Involvement of ZO-1 in Cadherin-based Cell Adhesion through Its Direct Binding to α Catenin and Actin Filaments , 1997, The Journal of cell biology.
[43] Kazushi Fujimoto,et al. Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.
[44] S. Tsukita,et al. Effects of tyrosine phosphorylation on tight junctions in temperature-sensitive v-src-transfected MDCK cells. , 1995, Cell structure and function.
[45] J. Scott,et al. Organization of kinases, phosphatases, and receptor signaling complexes. , 1999, The Journal of clinical investigation.
[46] Ivana K. Kim,et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.
[47] R. Lifton,et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. , 1999, Science.
[48] J. Cunha-Vaz,et al. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. , 1998, Experimental eye research.
[49] J. Spranger,et al. Growth Factor Alterations in Advanced Diabetic Retinopathy: A Possible Role of Blood Retina Barrier Breakdown , 1997, Diabetes.
[50] James M. Anderson,et al. The Tight Junction Protein ZO-1 Establishes a Link between the Transmembrane Protein Occludin and the Actin Cytoskeleton* , 1998, The Journal of Biological Chemistry.
[51] L. Aiello,et al. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. , 1997, Diabetes/metabolism reviews.
[52] J. W. Miller. Vascular endothelial growth factor and ocular neovascularization. , 1997, The American journal of pathology.
[53] M. Cooper,et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[54] D. Eliott,et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[55] M. Balda,et al. Occludin and the functions of tight junctions. , 1999, International review of cytology.
[56] J. Cunha-Vaz,et al. Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. , 1966, Experimental eye research.
[57] J. Alexander,et al. Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.
[58] A. Barber,et al. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. , 1997, Investigative ophthalmology & visual science.
[59] T. Noda,et al. Occludin-deficient Embryonic Stem Cells Can Differentiate into Polarized Epithelial Cells Bearing Tight Junctions , 1998, The Journal of cell biology.
[60] A. Patz,et al. Clinically significant macular edema in type I diabetes. Incidence and risk factors. , 1995, Ophthalmology.
[61] C. V. Van Itallie,et al. Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells. , 1995, Journal of cell science.
[62] L. Rubin,et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.
[63] B. Giepmans,et al. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein , 1998, Current Biology.
[64] P. Campochiaro,et al. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes , 1997, The British journal of ophthalmology.
[65] C. V. Van Itallie,et al. Zonula occludens (ZO)-1 and ZO-2: membrane-associated guanylate kinase homologues (MAGuKs) of the tight junction. , 1995, Biochemical Society transactions.
[66] J. Robertson,et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. , 1994, Investigative ophthalmology & visual science.
[67] Harold E. Dvorak,et al. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin , 1996, The Journal of experimental medicine.
[68] L. Rubin,et al. Evidence that tyrosine phosphorylation may increase tight junction permeability. , 1995, Journal of cell science.
[69] Joan W. Miller,et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.
[70] L. Aiello. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. , 1998, Ophthalmic research.